Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12
Conditions
Breast Cancer
Conditions: Keywords
Breast reconstruction, Hydroxyproline concentration, neoangiogenesis, collagen deposition
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Overall Status
Recruiting
Summary
The purpose of this study is to measure the level of AlloMax™ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 70 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM implants and agree to participate will be included in this study.

Exclusion Criteria:

- Patients who do not agree to be included in the study.
Location
University of Nevada School of Medicine
Las Vegas, Nevada, United States
Status: Recruiting
Contact: Sherree Mounts, LPN - 702-671-5117 - smounts@medicine.nevada.edu
Start Date
February 2014
Completion Date
November 2018
Sponsors
University of Nevada, Las Vegas
Source
University of Nevada, Las Vegas
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page